Myeloperoxidase Antibodies
Myeloperoxidase (MPO) is a peroxidase enzyme that in humans is encoded by the MPO gene on chromosome 17. MPO is a member of the XPO subfamily of peroxidases and produces hypochlorous acid (HOCl) from hydrogen peroxide (H2O2) and chloride anion (Cl−) (or the equivalent from a non-chlorine halide) during the neutrophil's respiratory burst. It requires heme as a cofactor. Antibodies against MPO have been implicated in various types of vasculitis, most prominently three clinically and pathologically recognized forms: granulomatosis with polyangiitis (GPA, formerly Wegener's granulomatosis), microscopic polyangiitis (MPA); and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg–Strauss syndrome).
Related Conference of Myeloperoxidase Antibodies
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
March 31-April 02 2016
2nd International Congress on Neuroimmunology and Therapeutics
Atlanta USA
October 24-26 2016
5th International Conference on Immunology
Chicago USA
July 21-22 2016
2nd International Conference on Innate Immunity
Berlin Germany
March 29-30 2016
International Allergy Conference
Valencia Spain
August 25-27 2016
2nd World Congress on Infectious Diseases
Philadelphia USA
July 28-30 2016
International Conference on Tumor Immunology and Immunotherapy
Melbourne Australia
August 01-03 2016
2nd International Conference on Parasitology
Manchester UK
July 28-29 2016
International Conference on Mucosal Immunology
Melbourne Australia
October 13-15 2016
International Conference on Autoimmunity
Manchester UK
July 28-30 2016
International Conference on Cancer Immunology and Immunotherapy
Melbourne Australia
March 20-25 2016
Antibody Biology Engineering
Galveston TX
April 18-19 2016
Proteins and Antibodies Congress
London UK
April 25-28 2016
8th Annual International Congress of Antibodies
Dalian China
May 8-13 2016
Cell Culture Engineering XV
California USA
December 7-10 2015
Antibody Engineering and Therapeutics
San Diego CA
April 25-29 2016
Protein and Antibody Engineering Summit
Boston MA
May 19-20 2016
Americas Antibody Congress
San Diego USA
September 27-29 2016
World Bispecific Antibody Summit
Boston MA
February 9-10 2016
Antibodies in Drug Discovery
Cambridge UK
March 6-11 2016
Antibodies as Drugs
Whistler Canada
February 25-26 2016
11th Annual Biomarkers Congress
Manchester UK
February 8-10 2016
6th World ADC Summit
Berlin Germany
April 12-13 2016
Bio Process International European Summit
Vienna Austria
January 21-22 2016
Bispecific Antibody Therapeutics
San Diego CA
April 5-7 2016
Protein Antibody Engineering and Development Summit
Pudong Shanghai China
Myeloperoxidase Antibodies Conference Speakers
Recommended Sessions
- Anti-Cancer Antibodies
- Antibodies Immunogenecity
- Antibodies in Pregnancy
- Antibodies Structure
- Antibody Drug Conjugate
- Antibody Drug Therapy
- Antibody Engineering
- Antibody Humanization Technologies
- Antibody Tests
- Antigens
- Auto Antibodies
- Autoimmune Antibodies
- Biomarkers Development
- Biosimilar monoclonal antibodies
- Cancer Immune therapy
- Hepatitis Antibodies
- Immunoglobulins Structures
- Immunotherapy and Immune Checkpoints
- Infectious Diseases
- Insulin and Diode Antibodies
- Medical Applications
- Monoclonal Antibody Therapy
- Myeloperoxidase Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)